Horizon Discovery - CHOSOURCEā„¢ expression platform
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search Capabilities

Tuesday, December 07, 2021

Recursion a clinicalstage biotechnology company decoding biology to radically improve lives by industrializing drug discovery development and beyond through disruptive innovation today announced expansion of the companys existing strategic collaborat...

Gritstone bio and CEPI Expand Vaccine Agreement to Tackle Omicron Variant

Tuesday, December 07, 2021

Gritstone bio Inc a clinicalstage biotechnology company developing next generation cancer and infectious disease immunotherapies and CEPI the Coalition for Epidemic Preparedness Innovations today announced the expansion of their agreement in order to...

Jacobio Receives IND Approval for Combination Therapy of KRAS G12C and Cetuximab Injection in China

Monday, December 06, 2021

Jacobio Pharma HK has received the Investigational New Drug the IND approval of the combination therapy of KRAS GC inhibitor JAB and Cetuximab injection from the Center for Drug Evaluation of China the CDE on Dec After received the approval Jacobi...

Resilience Acquires SwiftScale Biologics, a Leader in Cell-Free Protein Synthesis Technology

Friday, December 03, 2021

National Resilience Inc Resilience a technology focused manufacturing company dedicated to broadening access to complex medicines today announced the acquisition of SwiftScale Biologics a San Leandro Californiabased company developing cellfree protei...

NJ Bio Expands Its State-Of-The-Art Facility in Princeton, New Jersey

Friday, December 03, 2021

NJ Biopharmaceuticals LLC an expert provider of chemistry and biopharmaceutical services specializing in bioconjugation custom synthesis flow chemistry and process development has expanded its footprint at its stateoftheart laboratory and headquarter...

Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy

Thursday, December 02, 2021

Sanofi announced today it entered into an agreement to acquire Origimm Biotechnology GmbH an Austrian privately owned biotechnology company specializing in the discovery of virulent skin microbiome components and antigens from bacteria causing skin d...

Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle

Thursday, December 02, 2021

Astellas Pharma Inc and Dyno Therapeutics Inc announced an option and license agreement was signed on November to develop nextgeneration adenoassociated virus AAV vectors for gene therapy directed to skeletal and cardiac muscle using Dynos CapsidMap...

UCB and Chiesi enter global license agreement for zampilimab a novel monoclonal antibody for fibrotic lung diseases

Wednesday, December 01, 2021

UCB a global biopharmaceutical company and Chiesi Group the international researchfocused pharmaceutical and healthcare group are pleased to announce that they have entered into an agreement that grants Chiesi a worldwide exclusive license to develop...

Kymera Therapeutics Announces FDA Clearance of Investigational New Drug Application (IND) for IRAKIMiD Degrader, KT-413

Wednesday, December 01, 2021

Kymera Therapeutics Inc a clinicalstage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines today announced the clearance of its Investigational New Drug IND application from the...

Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics

Tuesday, November 30, 2021

Blueprint Medicines Corporation announced that the company has entered into a definitive agreement under which it will acquire Lengo Therapeutics a privately held precision oncology company for million in cash plus up to million in additional poten...

Latest Issue
Get instant
access to our latest e-book
Saving Money, Saving Time In Pharma Operations Eppendorf SE || LAB Channel Catalent  Asia-Pacific Clinical Supply Solutions SGS - Health Science Horizon - CHOSOURCE advances biotherapeutic production MasterControl - The Never-Normal Future of Manufacturing Medical Fair Thailand 2022 Meco - 90 years